Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Susan L Slager

Showing results (181-190 of 277) with videos related to

Pageof 28
Sort By:
American Journal of Hematology|September 24, 2017
Liver dysfunction in chronic lymphocytic leukemia: Prevalence, outcomes, and pathological findingsPaul J Hampel, Kari G Chaffee, Rebecca L King, et al.
Nutrition and Cancer|October 16, 2012
Associations between intake of folate and related micronutrients with molecularly defined colorectal cancer risks in the Iowa Women's Health StudyAnthony A Razzak, Amy S Oxentenko, Robert A Vierkant, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 20, 2009
Functional and clinical significance of variants localized to 8q24 in colon cancerMine S Cicek, Susan L Slager, Sara J Achenbach, et al.
Blood Cancer Journal|August 29, 2025
State of the art biology, progression, and clinical management of monoclonal B-cell lymphocytosis (MBL): consensus report from the Intercepting Blood Cancers Workshop CommitteeChristine E Ryan, Inhye E Ahn, Aswin Sekar, et al.
American Journal of Hematology|April 13, 2020
Tumor mutational load predicts time to first treatment in chronic lymphocytic leukemia (CLL) and monoclonal B-cell lymphocytosis beyond the CLL international prognostic indexGeffen Kleinstern, Daniel R O'Brien, Xing Li, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|March 25, 2010
Genetic susceptibility variants for chronic lymphocytic leukemiaSusan L Slager, Lynn R Goldin, Sara S Strom, et al.
Blood Cancer Journal|November 6, 2025
CHIP amplifies the risk of lymphoid malignancies in individuals with monoclonal B-cell lymphocytosis (MBL)Nicholas J Boddicker, Tait D Shanafelt, Sameer A Parikh, et al.
Cancer Medicine|March 19, 2020
The impact of dose modification and temporary interruption of ibrutinib on outcomes of chronic lymphocytic leukemia patients in routine clinical practiceSameer A Parikh, Sara J Achenbach, Timothy G Call, et al.
Blood Cancer Journal|January 9, 2026
Genome-wide association study of event-free survival in follicular lymphoma patients treated with front-line immunochemotherapyHervé Ghesquières, Youenn Drouet, Susan L Slager, et al.
British Journal of Haematology|July 15, 2025
The role of imaging studies in predicting time to first treatment and overall survival in high-count monoclonal B-cell lymphocytosisSamuel Kosydar, William J Archibald, Paul J Hampel, et al.
Pageof 28

Showing results (181-190 of 277) with videos related to

Sort By:
Pageof 28
American Journal of Hematology|September 24, 2017
Liver dysfunction in chronic lymphocytic leukemia: Prevalence, outcomes, and pathological findingsPaul J Hampel, Kari G Chaffee, Rebecca L King, et al.
Nutrition and Cancer|October 16, 2012
Associations between intake of folate and related micronutrients with molecularly defined colorectal cancer risks in the Iowa Women's Health StudyAnthony A Razzak, Amy S Oxentenko, Robert A Vierkant, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 20, 2009
Functional and clinical significance of variants localized to 8q24 in colon cancerMine S Cicek, Susan L Slager, Sara J Achenbach, et al.
Blood Cancer Journal|August 29, 2025
State of the art biology, progression, and clinical management of monoclonal B-cell lymphocytosis (MBL): consensus report from the Intercepting Blood Cancers Workshop CommitteeChristine E Ryan, Inhye E Ahn, Aswin Sekar, et al.
American Journal of Hematology|April 13, 2020
Tumor mutational load predicts time to first treatment in chronic lymphocytic leukemia (CLL) and monoclonal B-cell lymphocytosis beyond the CLL international prognostic indexGeffen Kleinstern, Daniel R O'Brien, Xing Li, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|March 25, 2010
Genetic susceptibility variants for chronic lymphocytic leukemiaSusan L Slager, Lynn R Goldin, Sara S Strom, et al.
Blood Cancer Journal|November 6, 2025
CHIP amplifies the risk of lymphoid malignancies in individuals with monoclonal B-cell lymphocytosis (MBL)Nicholas J Boddicker, Tait D Shanafelt, Sameer A Parikh, et al.
Cancer Medicine|March 19, 2020
The impact of dose modification and temporary interruption of ibrutinib on outcomes of chronic lymphocytic leukemia patients in routine clinical practiceSameer A Parikh, Sara J Achenbach, Timothy G Call, et al.
Blood Cancer Journal|January 9, 2026
Genome-wide association study of event-free survival in follicular lymphoma patients treated with front-line immunochemotherapyHervé Ghesquières, Youenn Drouet, Susan L Slager, et al.
British Journal of Haematology|July 15, 2025
The role of imaging studies in predicting time to first treatment and overall survival in high-count monoclonal B-cell lymphocytosisSamuel Kosydar, William J Archibald, Paul J Hampel, et al.
Pageof 28